Cargando…
Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence
BACKGROUND: Meningioma is the most common primary central nervous system neoplasm, accounting for about a third of all brain tumors. Because their growth rates and prognosis cannot be accurately estimated, biomarkers that enable prediction of their biological behavior would be clinically beneficial....
Autores principales: | Slavik, Hanus, Balik, Vladimir, Kokas, Filip Zavadil, Slavkovsky, Rastislav, Vrbkova, Jana, Rehulkova, Alona, Lausova, Tereza, Ehrmann, Jiri, Gurska, Sona, Uberall, Ivo, Hajduch, Marian, Srovnal, Josef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287111/ https://www.ncbi.nlm.nih.gov/pubmed/35551164 http://dx.doi.org/10.1227/neu.0000000000002026 |
Ejemplares similares
-
A Data-Driven Approach to Predicting 5-Aminolevulinic Acid–Induced Fluorescence and World Health Organization Grade in Newly Diagnosed Diffuse Gliomas
por: Müther, Michael, et al.
Publicado: (2022) -
Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling
por: Slavik, Hanus, et al.
Publicado: (2020) -
Early Diagnosis and Surgical Intervention Within 3 Weeks From Symptom Onset Are Associated With Prolonged Survival of Patients With Glioblastoma
por: Kawauchi, Daisuke, et al.
Publicado: (2022) -
Recent Advances in Methods for Circulating Tumor Cell Detection
por: Vidlarova, Monika, et al.
Publicado: (2023) -
Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety
por: Vitanza, Nicholas A., et al.
Publicado: (2023)